New Enterprise Associates 14, L.P. → Adaptimmune Therapeutics PLC

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Adaptimmune Therapeutics PLC

Filed	Form	Filer	Stake	Shares
2018-01-26	SC	ORBIMED ADVISORS LLC	—	—	view →

Other Filings by New Enterprise Associates 14, L.P.

Filed	Form	Issuer	Stake	Shares
2025-01-07	SCHEDULE	NEXTNAV INC. NXNVW	10.00%	75,627	view →
2018-05-14	SC	MULESOFT, INC	—	—	view →
2018-04-03	SC	Tracon Pharmaceuticals, Inc.	—	—	view →
2018-02-01	SC	SYNLOGIC, INC. SYBX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →